Effects of carnitine on oxidative stress response to intravenous iron administration to patients with CKD: impact of haptoglobin phenotype

[1] Levey AS(2007)Chronic kidney disease: common, harmful, and treatable--World Kidney Day 2007 Clin J Am Soc Nephrol 2 401-5

[2] Andreoli SP(2007)Prevalence of chronic kidney disease in the United States JAMA 298 2038-–47

[3] DuBose T(1997)Anemia in Renal Disease Dis Kidney 3 2581-92

[4] Provenzano R(2003)Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Circulation 108 2154-69

[5] Collins AJ(2004)Evidence for increased cardiovascular disease risk in patients with chronic kidney disease Curr Opin Nephrol Hypertens 13 73-81

[6] Coresh J(2004)Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 1296-305

[7] Selvin E(1997)Iron management in end-stage renal disease Am J Kidney Dis 29 319-33

[8] Stevens LA(2012)Mechanisms of anemia in CKD J Am Soc Nephrol 23 1631-4

[9] Manzi J(1999)Beneficial effects of adopting an aggressive intravenous iron policy in a hemodialysis unit Am J Kidney Dis 34 S40-6

[10] Kusek JW(2010)Iron supplementation to treat anemia in patients with chronic kidney disease Nat Rev Nephrol 6 699-710

[1] Levey AS(2007)Chronic kidney disease: common, harmful, and treatable--World Kidney Day 2007 Clin J Am Soc Nephrol 2 401-5

[2] Andreoli SP(2007)Prevalence of chronic kidney disease in the United States JAMA 298 2038-–47

[3] DuBose T(1997)Anemia in Renal Disease Dis Kidney 3 2581-92

[4] Provenzano R(2003)Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Circulation 108 2154-69

[5] Collins AJ(2004)Evidence for increased cardiovascular disease risk in patients with chronic kidney disease Curr Opin Nephrol Hypertens 13 73-81

[6] Coresh J(2004)Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 1296-305

[7] Selvin E(1997)Iron management in end-stage renal disease Am J Kidney Dis 29 319-33

[8] Stevens LA(2012)Mechanisms of anemia in CKD J Am Soc Nephrol 23 1631-4

[9] Manzi J(1999)Beneficial effects of adopting an aggressive intravenous iron policy in a hemodialysis unit Am J Kidney Dis 34 S40-6

[10] Kusek JW(2010)Iron supplementation to treat anemia in patients with chronic kidney disease Nat Rev Nephrol 6 699-710